Investing Ideas
/
Japanese Pharmaceuticals & Biotech Undervalued based on future growth

Japanese Pharmaceuticals & Biotech Undervalued based on future growth

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

Zeria Pharmaceutical

Market Cap: JP¥95.3b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

New

4559

JP¥2,211.00

-1.9%

0.2%